Skip to main content
. 2017 Feb 27;7:66. doi: 10.1038/s41598-017-00115-w

Table 1.

Summary of clinical and genetic information for studied GRIN2A mutations.

cDNA alteration Protein alteration Phenotype Inheritance, Segregation (Y/N) CADD Scaled Score Reference
c.236C > G P79R RE/ECSWS Maternal, Y 24.9 16
c.692G > A C231Y LKS Maternal, Y 26.7 16
c.1306T > C C436R ABPE de novo 27 16
c.1447G > A G483R ECSWS, aRE Maternal, N 34 17
c.2113A > G M705V RE Maternal, Y 25.6 16
c.2140G > A E714K ECSWS Unknown 23.4 16
c.2191G > A D731N aRE, VD Maternal, VD -Y 26.6 17
c.2441T > C I814T RE Paternal, N 21.5 16
c.2797G > A D933N LKS Paternal, N 28 17
c.2927A > G N976S ECSWS Unknown 7.2 16
ABPE Unknown

cDNA annotation based on the canonical transcript ENST00000396573. Phenotype abbreviations as follows: ABPE – atypical benign partial epilepsy, aRE – atypical Rolandic epilepsy, CSWS – epileptic encephalopathy with continuous spike and wave during slow wave sleep, LKS – Landau-Kleffner Syndrome, RE – Rolandic epilepsy, VD – verbal dyspraxia. Y-yes, N-no for segregation of variants with phenotype. CADD score stands for “combined annotation dependent depletion”, a tool for scoring the deleteriousness of single nucleotide variants and were generated using v1.3 on 19 May 2016 from http://cadd.gs.washington.edu/. A score > 20 indicates the top 1% most deleterious substitutions20.